Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

Safety and Tolerability of PNT001 in Healthy Adults

This first in human study is a multi-center, randomized, double-blind, placebo-controlled single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of intravenous PNT001 in healthy adult participants.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Biological - PNT001

PNT001 diluted in 5% dextrose

Drug - Placebo

5% dextrose

Additional Information

Official Study Title

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-Ascending-Dose Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Intravenous PNT001 in Healthy Volunteers

Clinical Trial ID

NCT04096287

ParticipAid ID

bo21ja